Discontinuation report NAROPIN
| Report ID | 260037 |
| Drug Identification Number | 02229411 |
| Brand name | NAROPIN |
| Common or Proper name | ropivacaine HCl 2mg/mL 5x100mL SU Polybag® |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL BLOCK/INFILTRATION BLOCK/INFILTRATION EPIDURAL |
| Packaging size | 5 PP Polybag |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2025-06-09 |
| Remaining supply date | 2025-06-09 |
| Discontinuation status | Reversed |
| Discontinuation decision reversal | Yes |
| Information on remaining supply | No remaining supply |
| Company comments | VR89890CA1 NAROPIN 2MG/ML LIQ POLYBAG 5X100ML CA AS |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-06-09 | French | Compare |
| v1 | 2025-06-09 | English | Compare |
Showing 1 to 2 of 2